Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:19:44 EDT Sat 12 Oct 2024
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

V:NRX - NurExone Biologic Inc. - http://www.nurexone.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NRX - V  2.00.56·0.5858.00.57-0.01-1.74.3280.57  0.57  0.571.19  0.2513:58:35Sep 2615 min RT 2¢
TSX-V - V2.00.56·0.5858.00.57-0.01-1.74.1260.57  0.57  0.571.19  0.2513:58:3515 min
CXD - D 0.580.202    Sep 1315 min

Recent Trades - All 8 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
13:58:35V0.57-0.0150036 Latimer1 AnonymousK
10:01:25D0.57-0.012007 TD Sec2 RBCE
10:01:25V0.57-0.011,0007 TD Sec1 AnonymousK
09:30:00D0.57-0.012580 National Bank1 AnonymousE
09:30:00V0.57-0.0110079 CIBC36 Latimer
09:30:00V0.57-0.0150079 CIBC1 AnonymousKL
09:30:00V0.57-0.011,00079 CIBC79 CIBCKL
09:30:00V0.57-0.011,00079 CIBC79 CIBCKL
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-09-26 18:08C:NRX0.57News ReleaseNurexone closes $1.61M first tranche of financing
2024-09-06 16:48C:NRX0.56News ReleaseNurexone finds one-week window for ExoPTEN use
2024-08-28 19:06C:NRX0.63News ReleaseNurexone spends $510,000 (U.S.) on R&D in Q2 2024
2024-08-28 14:41C:NRX0.65SEDAR Annual Information FormSEDAR Annual Information Form
2024-08-27 17:18C:NRX0.65SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-27 17:18C:NRX0.65SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-15 17:37C:NRX0.59News ReleaseNurexone talks exosome manufacturing process
2024-08-09 16:19C:NRX0.59News ReleaseNurexone's ExoPTEN shows homing capacity in study
2024-08-01 17:20C:NRX0.64News ReleaseNurexone transfers tech to GMP-compliant vendor
2024-07-29 16:04C:NRX0.61News ReleaseNurExone Announces Further Expansion of ExoPTEN Patent Coverage
2024-07-17 19:46C:NRX0.69News ReleaseNurexone receives preliminary results of ExoPTEN study
2024-07-05 08:43C:NRX0.69News ReleaseUpdates from NurExone: Growth Conference Presentation and Website Relaunch
2024-06-28 16:46C:NRX0.66News ReleaseNurexone's Exopten to go through preclinical study
2024-06-21 16:27C:NRX0.62News ReleaseNurexone appoints Geffen as consultant
2024-06-11 12:32C:NRX0.495News ReleaseNurexone Biologic receives ExoPTEN patent in Japan
2024-06-04 16:45C:NRX0.47News ReleaseNurexone shareholders approve all matters at meeting
2024-05-29 17:18C:NRX0.53SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-29 17:18C:NRX0.53SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-29 13:10C:NRX0.49News ReleaseNurexone spends $22,000 (U.S.) on R&D in Q1
2024-05-17 16:11C:NRX0.49News ReleaseNurexone Biologic appoints Petter consultant